Goodwin Procter LLP advised Caresyntax on the deal.Caresyntax announced the completion of its $100 million Series C funding round led by PFM Health Sciences LP, and included…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
